vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
37.69
-0.64 (-1.67%)
At close: Apr 15, 2026, 4:00 PM EDT
37.72
+0.03 (0.08%)
After-hours: Apr 15, 2026, 4:10 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $468.09 million as of April 15, 2026. Its market cap has increased by 378.84% in one year.
Market Cap
468.09M
Enterprise Value
379.16M
1-Year Change
378.84%
Ranking
Category
Stock Price
$37.69
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $468.09M, an increase of 499.15%. That is a compound annual growth rate of 18.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 468.08M | -5.67% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 492.93M |
| 4D Molecular Therapeutics | 492.14M |
| REGENXBIO | 483.14M |
| Contineum Therapeutics | 483.13M |
| Absci | 481.25M |
| XOMA Royalty | 470.08M |
| Sutro Biopharma | 465.71M |
| Assembly Biosciences | 465.41M |